14-day Premium Trial Subscription Sign Up For FreeGet Free

Acasti Pharma Stock Forecast NASDAQ:ACST

Price Target and Analyst Ratings

Most Recent Rating

B. Riley does not see either upside or downside right now giving ACST "Buy - Neutral" on their last update on September 01, 2020. The price target was changed from $2.00 to $0.50.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2020-09-02 Buy - Hold Downgraded by Aegis $0.22
2020-09-01 Buy - Neutral Target Lowered by B. Riley $0.22 $2.00 → $0.50
2020-08-31 Outperform - Market Perform Downgraded by Oppenheimer $0.24
2020-08-14 Buy Reiterated by HC Wainwright $0.71 $3.00
2020-07-06 Neutral - Buy Upgraded by B. Riley $0.61 $2.00
2020-06-30 Buy Reiterated by Oppenheimer $0.47 $7.00
2020-06-30 Buy Reiterated by Echelon Wealth Partners $0.47 $1.40
2020-06-23 Hold Downgraded by B. Riley $0.72 $2.00
2020-05-06 Buy Target Lowered by Aegis $0.61 $3.00 → $2.15

ACST Stock Trend

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled.

Given the current short-term trend, the stock is expected to rise 111.76% during the next 3 months and, with a 90% probability hold a price between $1.48 and $6.23 at the end of this 3-month period.

Data

Date Bottom Mid Top
2021-09-20 $0.72 $1.84 $2.97
2021-09-21 $0.75 $1.87 $2.99
2021-09-22 $0.77 $1.89 $3.01
2021-09-23 $0.80 $1.92 $3.04
2021-09-24 $0.82 $1.94 $3.06
2021-09-27 $0.84 $1.97 $3.09
2021-09-28 $0.87 $1.99 $3.11
2021-09-29 $0.89 $2.02 $3.14
2021-09-30 $0.92 $2.04 $3.16
2021-10-01 $0.94 $2.07 $3.19
2021-10-04 $0.97 $2.09 $3.21
2021-10-05 $0.99 $2.11 $3.24
2021-10-06 $1.02 $2.14 $3.26
2021-10-07 $1.04 $2.16 $3.29
2021-10-08 $1.07 $2.19 $3.31
2021-10-11 $1.09 $2.21 $3.34
2021-10-12 $1.12 $2.24 $3.36
2021-10-13 $1.14 $2.26 $3.38
2021-10-14 $1.16 $2.29 $3.41
2021-10-15 $1.19 $2.31 $3.43
2021-10-18 $1.21 $2.34 $3.46
2021-10-19 $1.24 $2.36 $3.48
2021-10-20 $1.26 $2.39 $3.51
2021-10-21 $1.29 $2.41 $3.53
2021-10-22 $1.31 $2.43 $3.56
2021-10-25 $1.34 $2.46 $3.58
2021-10-26 $1.36 $2.48 $3.61
2021-10-27 $1.39 $2.51 $3.63
2021-10-28 $1.41 $2.53 $3.66
2021-10-29 $1.44 $2.56 $3.68

About Acasti Pharma

Acasti Pharma Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of therapies for the treatment of various cardiometabolic disorders primarily abnormalities in blood lipids. The company offers Onemia, a medical food product for the dietary management of omega-3 phospholipids deficiency, and related abnormal lipid profiles and cardiometabolic disorders. It also develops CaPre, a prescription drug candida... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT